Compounds > omega-n-methylarginine
Page last updated: 2024-09-03

omega-n-methylarginine and raloxifene hydrochloride

omega-n-methylarginine has been researched along with raloxifene hydrochloride in 1 studies

Compound Research Comparison

Studies
(omega-n-methylarginine)		Trials
(omega-n-methylarginine)		Recent Studies (post-2010)
(omega-n-methylarginine)		Studies
(raloxifene hydrochloride)		Trials
(raloxifene hydrochloride)		Recent Studies (post-2010) (raloxifene hydrochloride)
4,4113443362,818481810

Protein Interaction Comparison

ProteinTaxonomyomega-n-methylarginine (IC50)raloxifene hydrochloride (IC50)
Estrogen receptorHomo sapiens (human)0.0053
Gastric inhibitory polypeptide receptorHomo sapiens (human)0.0004
Estrogen receptor betaHomo sapiens (human)0.1297

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carbonella, M; Colacurci, N; Fornaro, F; Manzella, D; Paolisso, G1

Trials

1 trial(s) available for omega-n-methylarginine and raloxifene hydrochloride

ArticleYear
Endothelial function and menopause: effects of raloxifene administration.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:5

    Topics: Adult; Blood Flow Velocity; Brachial Artery; Cholesterol, LDL; Chromans; Double-Blind Method; E-Selectin; Endothelium, Vascular; Female; Humans; Intercellular Adhesion Molecule-1; Menopause; omega-N-Methylarginine; Placebos; Postmenopause; Premenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiobarbituric Acid Reactive Substances; Triglycerides; Vascular Cell Adhesion Molecule-1; Vasodilation

2003